SCHEMBL8311767

SCHEMBL8311767

O=C(c1ccc(Nc2nccc(-c3ccc(Cl)cc3)n2)cc1)N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14063828 0.86 CAMK2D (0.61) —
SCHEMBL8311361 0.86 IKBKB (0.56) —
SCHEMBL14063851 0.85 IKBKB (0.51) —
SCHEMBL14021219 0.82 PIK3CA (0.58) —
SCHEMBL14021414 0.82 IKBKB (0.52) —
SCHEMBL14021251 0.82 JAK2 (0.57) —
SCHEMBL14021222 0.82 PIK3CA (0.53) —
SCHEMBL1512786 0.81 PIK3CA (0.55) SYK
SCHEMBL8312148 0.81 CDK1 (0.62) —
SCHEMBL3048434 0.81 IKBKB (0.66) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 — — WO disclosed
Send feedback